Skip to main content

Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.

Publication ,  Conference
Ghiaseddin, A; Reardon, DA; Massey, W; Mannerino, A; Lipp, ES; Herndon, JE; McSherry, F; Desjardins, A; Randazzo, DM; Vlahovic, G; Friedman, HS ...
Published in: Journal of Clinical Oncology
May 20, 2015

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

2034 / 2034

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ghiaseddin, A., Reardon, D. A., Massey, W., Mannerino, A., Lipp, E. S., Herndon, J. E., … Peters, K. B. (2015). Phase II study of bevacizumab and vorinostat for recurrent glioblastoma. In Journal of Clinical Oncology (Vol. 33, pp. 2034–2034). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.2034
Ghiaseddin, Ashley, David A. Reardon, Woody Massey, Alexandra Mannerino, Eric S. Lipp, James E. Herndon, Frances McSherry, et al. “Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.” In Journal of Clinical Oncology, 33:2034–2034. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.2034.
Ghiaseddin A, Reardon DA, Massey W, Mannerino A, Lipp ES, Herndon JE, et al. Phase II study of bevacizumab and vorinostat for recurrent glioblastoma. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 2034–2034.
Ghiaseddin, Ashley, et al. “Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 2034–2034. Crossref, doi:10.1200/jco.2015.33.15_suppl.2034.
Ghiaseddin A, Reardon DA, Massey W, Mannerino A, Lipp ES, Herndon JE, McSherry F, Desjardins A, Randazzo DM, Vlahovic G, Friedman HS, Peters KB. Phase II study of bevacizumab and vorinostat for recurrent glioblastoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 2034–2034.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

2034 / 2034

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences